Media Summary: Publication (executive video brief & analysis): AACR ... Dr. Susan Galbraith, executive vice-president of oncology and R&D at AstraZeneca, discusses the healthcare giant's $2.4bn ... Dr. McDermott discusses his recently published article in JACS, Impact of Clinician Linkage on Unequal Access to High-Volume ...
Accustem Sciences Agrees To Joint - Detailed Analysis & Overview
Publication (executive video brief & analysis): AACR ... Dr. Susan Galbraith, executive vice-president of oncology and R&D at AstraZeneca, discusses the healthcare giant's $2.4bn ... Dr. McDermott discusses his recently published article in JACS, Impact of Clinician Linkage on Unequal Access to High-Volume ... Panel: Oncology Panelists: Dr. Michael Morrissey, President & CEO, Exelixis Dr. Paul-Peter Tak, President & CEO, Candel ... Dr. Bill Dalton, Founder, Aster Insights, and Dr. Eric Rubin, SVP, Clinical Oncology at Merck, discuss collaboration and the impact ... SU2C's Innovative Research Grants (IRGs) support cutting-edge cancer research that might not receive funding through ...
A discussion on cancer survivorship with members of the AACR Annual Meeting Scientist↔Survivor Program®, moderated by ... Dr. Jerry Zhu discusses how cell proliferations and differentiations are regulated, and how that affects cancer cells and treatment. International Workshop on NASH Biomarkers 2017 Speaker: Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP Presented at ... Immune engineers Darrell Irvine and Dane Wittrup join Ankyra Therapeutics CEO Howard Kaufman to discuss the evolution of a ...
